类视黄醇NEt-3IB促进常驻巨噬细胞基因表达并缓解干燥诱导的眼表疾病
该研究在小鼠干燥应激干眼模型中局部施用类视黄醇NEt-3IB(5 µM,每日三次,共5天),通过单细胞RNA测序等方法发现NEt-3IB显著上调结膜单核/巨噬细胞的稳态、吞噬和抗炎基因表达,抑制炎症基因特征,并降低角膜通透性、增加结膜杯状细胞面积。体外实验显示NEt-3IB与地塞米松均抑制炎症介质,但NEt-3IB独特增强Igf1和Il10等稳态因子表达。提示类视黄醇疗法可能通过刺激内源性稳态/抗炎因子产生来治疗干眼。
要点
- NEt-3IB局部点眼5天可抑制结膜单核/巨噬细胞炎症基因并促进稳态、吞噬、抗炎基因表达。
- NEt-3IB降低角膜 dextran 通透性(P=0.001)并增大结膜杯状细胞总面积(P=0.001)和单细胞面积(P=0.01)。
- 体外NEt-3IB与地塞米松均抑制炎症介质,但NEt-3IB增强Igf1和Il10表达。
核心结论
- 类视黄醇NEt-3IB在干燥应激诱导的眼表疾病中抑制单核/巨噬细胞谱系炎症基因并刺激稳态基因表达。
- NEt-3IB可能通过刺激内源性稳态/抗炎因子产生成为治疗干眼的新方法。
研究设计与样本
- 小鼠干燥应激干眼模型,局部给予NEt-3IB(5 µM)或溶剂对照,每日三次,共5天。
- 采用单细胞RNA测序分析结膜免疫细胞基因表达,并用RNA-seq评估LPS刺激下培养单核细胞经地塞米松(1 µM)或NEt-3IB(1-1000 nM)处理的基因表达。
- 使用scVelo推断细胞状态轨迹和潜在时间,Monocle 3鉴定潜在时间相关基因。
- 通过Oregon Green标记dextran评估角膜屏障通透性,PAS染色全mount测量结膜杯状细胞参数。
主要发现
- 与溶剂对照相比,NEt-3IB显著刺激结膜单核/巨噬细胞的稳态、吞噬和抗炎基因表达并抑制炎症基因特征(Padj < 0.05)。
- 潜在时间轨迹分析和流式细胞术显示NEt-3IB preserved常驻巨噬细胞相关基因和蛋白表达。
- 与溶剂对照相比,NEt-3IB组角膜标记dextran摄取更低(P = 0.001),结膜杯状细胞总面积(P = 0.001)和单细胞面积(P = 0.01)更高。
- NEt-3IB对培养单核细胞差异表达基因的影响与体内效应一致。
- NEt-3IB和地塞米松均抑制炎症介质表达,但NEt-3IB增强稳态因子Igf1和Il10的表达。
关键数值与推荐
- NEt-3IB局部用药浓度5 µM,每日三次,持续5天。
- 培养单核细胞中NEt-3IB浓度范围为1-1000 nM,地塞米松浓度为1 µM。
- NEt-3IB组角膜dextran摄取较溶剂对照低(P = 0.001)。
- NEt-3IB组结膜杯状细胞总面积(P = 0.001)和单细胞面积(P = 0.01)均高于溶剂对照。
临床怎么用
- NEt-3IB局部点眼在动物模型中改善干燥应激所致眼表损伤,提示类视黄醇可能成为干眼治疗新选择。
- 其作用机制与促进单核/巨噬细胞稳态和抗炎基因表达、增强Igf1和Il10有关,不同于单纯抗炎。
局限性
- 研究仅在小鼠模型中进行,尚未在人体验证。
- NEt-3IB的长期安全性和最佳剂量方案未在原文中报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the effects of rexinoid NEt-3IB on desiccating stress-induced dry eye, as well as monocyte/macrophage gene expression and cellular trajectory. METHODS: Eyes were topically treated with rexinoid NEt-3IB (5 µM) or vehicle three times a day for 5 days of desiccating stress-induced dry eye. Single-cell RNA sequencing (RNA-seq) profiled gene expression in conjunctival immune cells. RNA-seq was also used to evaluate gene expression in lipopolysaccharide (LPS)-stimulated, dexamethasone-treated (Dex, 1 µM), or NEt-3IB-treated (1-1000 nM) cultured monocytes. Cellular state trajectory and latent time were inferred with scVelo, and latent-time-associated genes were identified using Monocle 3. Permeability to Oregon Green-labeled dextran was used to assess corneal barrier, and conjunctival goblet cell parameters were measured in periodic acid-Schiff (PAS)-stained wholemounts. RESULTS: NEt-3IB significantly stimulated homeostatic, phagocytotic, and anti-inflammatory gene expression and suppressed inflammatory gene signatures in conjunctival monocyte/macrophage cells compared to vehicle (Padj < 0.05). Latent time trajectory analysis and flow cytometry further revealed that NEt-3IB preserved resident macrophage-associated gene and protein expression. Compared to vehicle, corneal labeled dextran uptake was lower (P = 0.001) and conjunctival goblet cell total (P = 0.001) and single-cell (P = 0.01) areas were higher in the NEt-3IB group. The impact of NEt-3IB on differentially expressed genes in cultured monocytes mirrored its effects in vivo. NEt-3IB and dexamethasone suppressed inflammatory mediator expression; however, NEt-3IB enhanced the expression of homeostatic factors, including Igf1 and Il10. CONCLUSIONS: Rexinoid NEt-3IB suppresses inflammatory and stimulates homeostatic gene expression in the monocyte/macrophage lineage and desiccation-induced ocular surface disease. Rexinoid therapy may prove to be a novel approach to treat dry eye by stimulating endogenous production of homeostatic/anti-inflammatory factors.
引用
- Alam J, Qu Y, Shao J, et al. Rexinoid NEt-3IB Promotes Resident Macrophage Gene Expression and Mitigates Desiccation-Induced Ocular Surface Disease. Invest Ophthalmol Vis Sci. 2026. PMID: 41979250. doi:10.1167/iovs.67.4.31
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。